Valuation dashboard for Sight Sciences, Inc. (SGHT) with P/E N/A, P/B 8.43, EV/EBITDA -15.74 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients.
Analysis Summary
Sight Sciences, Inc. reported revenue of $77.4M in the most recent fiscal year, growing at a 5-year CAGR of 22.9%.
Trailing-twelve-month margins: gross margin 88.0%, operating margin -33.4%, net margin -35.7%.
At the current price of $8.14, SGHT has negative trailing earnings (P/E not meaningful) and an ROE of -50.64%. Market capitalisation stands at $443M.
Balance sheet quality for SGHT: current ratio of 10.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 8.43 |
| EV / EBITDA | -15.74 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SGHT | Sight Sciences, Inc. | $443M | 8.43 | -50.6% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $8.14 |
| Market Cap | $443M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -50.64% |
| Return on Invested Capital | -29.34% |
| Return on Assets | -28.37% |
| Gross Margin | 87.96% |
| Operating Margin | -33.43% |
| Net Margin | -35.69% |
Related companies: CERS · CVRX · LFCR · MASS · OMI · PRQR · QTRX
Explore sector: Healthcare · Medical - Devices
More sections of SGHT: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks